Burning Rock Biotech Limited (BNR)

Every figure this model derived for BNR, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 751,000 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 68,409,000 CashAndCashEquivalentsAtCarryingValue 2025-12-31
current assets 105,616,000 AssetsCurrent 2025-12-31
current liabilities 35,318,000 LiabilitiesCurrent 2025-12-31
equity 76,542,000 StockholdersEquity 2025-12-31
interest expense 4,000 InterestPaidNet 2025-12-31
ocf -4,068,000 NetCashProvidedByUsedInOperatingActivities 2025-12-31
revenue 77,157,000 Revenues 2025-12-31
sbc 1,984,000 ShareBasedCompensation 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up BNR on one particular measure came for.

RatioValue
cash operating margin-3.56
current ratio5.31
current ratio reported2.99
deferred revenue growth-4.54
fcf margin-6.25
growth cv2.83
interest cover-1961.0
operating margin-10.17
owner earnings margin-8.82
revenue growth9.18
revenue growth per share9.18
roic-73.98
rpo growth4.67
rule of 40-0.98
sbc pct revenue2.57

What to be careful about

What this model itself distrusts about BNR's figures. Written by the derivation as it ran, not added afterwards.